These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7181576)

  • 1. A study of dopamine receptors in guinea-pig renal tissue.
    Marcou M; Munday KA; Horn N; Woodruff GN
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):59-71. PubMed ID: 7181576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repartition and drug sensitivity of dopamine and L-isoproterenol-sensitive adenylate cyclases in rat brain homogenates.
    Prémont J; Tassin JP; Thierry AM; Bockaert J
    Adv Biochem Psychopharmacol; 1976; 15():347-56. PubMed ID: 192054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
    Gnegy ME; Bernabei A; Treisman G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ; Battaglia G; Norman AB; Creese I
    Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dopamine receptor activation on ganglionic transmission and cyclic AMP levels in the stellate ganglia and renal arteries of the dog.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    J Pharmacol Exp Ther; 1987 Jan; 240(1):93-8. PubMed ID: 2879905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of dopamine and beta-adrenergic agonists on adenylate cyclase of renal glomeruli and striatum.
    Kotake C; Hoffmann PC; Goldberg LI; Cannon JG
    Mol Pharmacol; 1981 Sep; 20(2):429-34. PubMed ID: 6117789
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
    Lau YS; Runice C; Dowd F
    J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Castration blocks chronic sulpiride-induced desensitization of striatal D1 receptor-stimulated adenylate cyclase activity in male rats.
    Ryan-Jastrow T; Gnegy ME
    J Pharmacol Exp Ther; 1989 Feb; 248(2):626-31. PubMed ID: 2521900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
    Barton AC; Black LE; Sibley DR
    Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenoceptor-mediated inhibition of alpha 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig.
    Haynes JM; Hill SJ
    Br J Pharmacol; 1997 Nov; 122(6):1067-74. PubMed ID: 9401771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of the adenylate cyclase-coupled adenosine receptor in isolated guinea pig atrial myocytes.
    Wilken A; Tawfik-Schlieper H; Klotz KN; Schwabe U
    Mol Pharmacol; 1990 Jun; 37(6):916-20. PubMed ID: 2163017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of dopamine-4-O-sulfate.
    Ackerman DM; Hieble JP; Sarau HM; Jain TC
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):241-8. PubMed ID: 6712357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
    Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG
    Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
    McGonigle P; Boyson SJ; Reuter S; Molinoff PB
    Synapse; 1989; 3(1):74-82. PubMed ID: 2521960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
    Seiler MP; Markstein R
    Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
    [No Abstract]   [Full Text] [Related]  

  • 20. The activity of substituted benzamides in biochemical models of dopamine receptors.
    Kebabian JW; Tsuruta K; Cote TE; Grewe CW
    Adv Biochem Psychopharmacol; 1982; 35():17-49. PubMed ID: 6293277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.